Navigation Links
Trial Date Set for Victim Hit by Ambulance
Date:3/24/2008

Louis Del Barba Severely Crippled in Crash in Oakley, California, Last Year

SAN MATEO, Calif., March 24 /PRNewswire/ -- April is set for the trial date of Louis Del Barba vs. American Medical Response, Inc., in Superior Court, County of Alameda, for damages when an ambulance driven by the defendant hit a car driven by Mr. Del Barba. According to police reports, the ambulance was traveling about 70 miles an hour in a 35 mile an hour zone during rush hour traffic. Mr. Del Barba had the right of way when he entered the intersection of Rose Avenue and Main Street. The ensuing crash caused catastrophic injuries to Mr. Del Barba, resulting in quadriplegia and brain damage. The plaintiff was wearing a shoulder and lap belt at the time of the crash.

AMR, a national company, which also owns and operates thousands of school buses, has a history of very serious accidents. Allowing poorly-trained drivers to far exceed speed limits in city traffic endangers all drivers, AMR officials admit.

Terry O'Reilly, attorney for Mr. Del Barba, noted that the ambulance was going far in excess of the speed allowed. "American Medical Response guidelines state that its ambulances can go 10 to 15 miles an hour over the speed limit but Vehicle Code regulations clearly state that an ambulance has the duty of due care to ensure it does not cause an accident on the way to a response. This driver launched himself into a blind intersection without the slightest care for anyone who might be in it."

Witnesses say that the ambulance was driving so fast that no one in the intersection saw or heard any warning until the ambulance slammed into Mr. Del Barba.

The Del Barba family has farmed in Oakley since 1935 and are well-known and popular members of this community in the Sacramento Delta. The community is stunned at Mr. Del Barba's injury.

It will take more than $20,000,000 to care for Mr. Del Barba for his predicted lifespan.

Case number is HG07352258.


'/>"/>
SOURCE Terry O'Reilly
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Genetic Engineering & Biotechnology News reports on clinical trials in developing countries
2. Only 2 percent of child drug trials have independent safety checks
3. Melt-Away Stent Works Well in Trial
4. The Lancet publishes first clinical trial data of a fully bioabsorbable drug-eluting stent
5. MGH initiates phase I diabetes trial
6. Peregrine Pharmaceuticals Announces Positive Data From Cotara(R) Brain Cancer Trials
7. Labopharm Initiates Phase III Clinical Trial for Twice-Daily Formulation of Tramadol-Acetaminophen
8. Akela Pharma initiates its first abuse deterrent opioid Phase I clinical trial
9. Quintiles Data Management Surpasses 300 EDC Trials
10. Sensor necklace aims to increase elderly and clinical trial participant drug compliance
11. Cancer risk slightly higher for women in discontinued hormone treatment trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... ... Leading pediatric oncology experts at Children’s National Health System will join ... International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired by Jeffrey Dome, ... at Children’s National, and Stephen P. Hunger, M.D., Chief of the Division of ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... of Michigan’s 2017 Best and Brightest in Wellness® by Best and Brightest. OnSite ... program on Friday, Oct. 20 from 7:30 a.m. to 2 p.m. at the ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... of $3,296 in property taxes a year. In some states—like New York, New ... , By contrast, many overseas retirement havens have extremely low property-tax rates, which ...
(Date:10/12/2017)... ... October 12, 2017 , ... Farm Forward ... and other leading institutions in announcing the launch of the Leadership Circle ... way animals are raised for food. , Founding members of the Leadership Circle ...
(Date:10/12/2017)... ... October 12, 2017 , ... Nvision Biomedical Technologies , ... the addition of industry sales leader, Thomas (Tom) Slott, as Senior Vice President ... and sales network, direct the efforts of the surgical sales teams, manage contractual ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... YORK , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a ... today announced that its MyDario product is expected to appear on The ... when The Dr. Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. Oz ... The ...
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, Inc. ... response letter from the U.S. Food and Drug Administration ... of sirukumab for the treatment of moderately to severely ... additional clinical data are needed to further evaluate the ... severely active RA. ...
(Date:9/19/2017)... a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses pulsed ...   ... Jim Bertolina, ... Tom Tefft ... medical device executive Josh Stopek , PhD, who has led R&D and business development ...
Breaking Medicine Technology: